Arrowhead Research is a clinical stage targeted therapeutics company that has development programs in oncology, obesity and infectious disease. The company utilizes its platform technologies in designing and developing peptide-drug conjugates (PDCs), which specifically home to cell types of interest while sparing off-target tissues. Arrowhead research also creates targeted drugs based on the gene-silencing RNA interference (RNAi) mechanism and collaborates with partners to create improved versions of traditional small molecule drugs. For more information, visit the company’s Web site at www.arrowheadresearch.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: